Bioventus (BVS) Shares Issued (2021 - 2026)

Bioventus (BVS) has 6 years of Shares Issued data on file, last reported at $120000.0 in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued fell 20.0% year-over-year to $120000.0; the trailing twelve-month figure through Mar 2026 stood at $2.0 million (down 15.36% YoY), and the FY2025 full-year result was $2.1 million, down 15.07% from the prior year.
• Shares Issued for Q1 2026 stood at $120000.0, down from $511000.0 in the prior quarter.
• Across five years, Shares Issued topped out at $2.2 million in Q3 2022 and bottomed at $84000.0 in Q2 2023.
• The 5-year median for Shares Issued is $482000.0 (2022), against an average of $660941.2.
• Peak annual rise in Shares Issued reached 12900.0% in 2022, while the deepest fall reached 99.55% in 2022.
• A 5-year view of Shares Issued shows it stood at $1.1 million in 2022, then slumped by 85.41% to $158000.0 in 2023, then jumped by 598.1% to $1.1 million in 2024, then slumped by 53.67% to $511000.0 in 2025, then plunged by 76.52% to $120000.0 in 2026.
• The last three Shares Issued figures came in at $120000.0 (Q1 2026), $511000.0 (Q4 2025), and $96000.0 (Q3 2025), per Business Quant data.

Peer Comparison